Nihal Tugcu received her B.S. in chemical engineering from Bogazici University, Turkey in 1997. She received her Ph.D. in chemical engineering at Rensselaer Polytechnic Institute in 2002 under the supervision of Prof. Steven M. Cramer. Her work focused on designing high affinity displacers to be used for displacement chromatography. She also investigated the effect of resin chemistry and mobile phase conditions on protein retention and displacer efficacy. After receiving her Ph.D., Nihal has worked for 19 years in the biopharmaceutical industry developing processes for manufacturing of biological drug candidates. Nihal was part of the Biologics Process Development and Clinical Manufacturing department at MSD in Kenilworth, New Jersey for 16 years in different capacities. Nihal currently works at Sanofi as Global Head for Mammalian Platform Process Development and Clinical Manufacturing overseeing advancement of Sanofi’s biologics pipeline from early stages through commercialization. In this role, along with her team, Nihal also focuses on advanced manufacturing technologies to decrease footprint, increase productivity and decrease cost of goods (COGs), as well as evaluating associated process analytical technologies for enhanced characterization and knowledge.
Nihal has over 20 peer reviewed publications, including book chapters. Nihal has been a member of the American Chemical Society (ACS) since 1999, and has been actively involved with the ACS Biotechnology division (BIOT) at different capacities over the last few years, including Conference Co-Chair, Downstream Processing Area Coordinator, and conference session co-chair. Nihal is the programming co-chair for the upcoming Recovery of Biological Products meeting in 2022, Rome, Italy. Nihal has also been a member of the American Institute of Chemical Engineers (AIChE).